Recommendation ID
What is the effectiveness of statins and/or other LDL-cholesterol-lowering treatment in people with type 1 diabetes?
Any explanatory notes
(if applicable)
People with type 1 diabetes have increased CVD risk derived from age, sex, glycaemia, blood pressure, renal function and lipid levels as identified in epidemiological studies. Long-term glycaemic control is associated with better outcomes but no trial has investigated the efficacy of statin therapy or other LDL-cholesterol-lowering therapies exclusively in people with type 1 diabetes.

Source guidance details

Comes from guidance
Cardiovascular disease: risk assessment and reduction, including lipid modification
Date issued
July 2014

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 07/10/2014